Acer Therapeutics stock resumes trading, plunges 79% premarket after receiving CRL from FDA



This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.


Read on The Source